Arcutis Biotherapeutics Stock (NASDAQ: ARQT) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 5.00 / 2.46M |
Day Range | - - - |
52 Wk Range | 1.76 - 13.17 |
Market Cap | $1.20B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 52 |
Short Interest | 26.13% |
Days to Cover | 10.62 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Arcutis Biotherapeutics (NASDAQ:ARQT) through any online brokerage.
Other companies in Arcutis Biotherapeutics’s space includes: Immunome (NASDAQ:IMNM), ARS Pharmaceuticals (NASDAQ:SPRY), Gyre Therapeutics (NASDAQ:GYRE), Cogent Biosciences (NASDAQ:COGT) and Immatics (NASDAQ:IMTX).
Arcutis Biotherapeutics has a consensus price target of $28.09.
The stock price for Arcutis Biotherapeutics (NASDAQ: ARQT) is $10.3 last updated September 20, 2024 at 5:22 PM EDT.
There are no upcoming dividends for Arcutis Biotherapeutics.
Arcutis Biotherapeutics’s Q3 earnings are confirmed for Friday, November 1, 2024.
There is no upcoming split for Arcutis Biotherapeutics.
Arcutis Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.